UBS announced a net profit of $1.4 billion for the second quarter of 2019.Earningsread more
Japan and South Korea are part of a complex and tightly linked supply chain that produces electronic goods such as smartphones and laptops.Technologyread more
Michael Kugelman from the U.S.-based Wilson Center says other issues take precedence in the bilateral dialogue between the United States and Pakistan — namely, Afghanistan and...Asia Politicsread more
Beijing says it can still meet its 2019 growth target of between 6% and 6.5% and continues to roll out stimulus measures to prop up activity. China set a 2019 industrial...China Economyread more
A different oil pricing dynamic has been evolving with new supply calculations based on the U.S. as the world's largest producer.Market Insiderread more
The Massachusetts senator's alarm-sounding on consumer debt neglects to measure it against the growth in the economy and the ability to pay.Economyread more
Stocks in Asia Pacific edged up on Tuesday afternoon, as investors await closely-watched central bank meetings in the coming days.Asia Marketsread more
More than half of Venezuela's 23 states lost power on Monday, according to Reuters witnesses and reports on social media, a blackout the government blamed on an...World Politicsread more
Equifax will give consumers a range of options for monitoring their credit or making claims of fraud or data misuse, part of a $425 million restitution fund.Technologyread more
The deal between the White House and Democrats was earlier expected to raise the debt ceiling for two years and permanently end the sequester.Politicsread more
Britain's Antstream is jumping into the cloud gaming battle with a streaming platform for retro titles. And Tencent just backed the company.Technologyread more
Federal prosecutors on Friday filed an additional charge in the fraud case against Martin Shkreli, the bad boy ex-pharmaceutical executive.
Prosecutors and defense lawyers said last month that he could be hit with a new count. Asked for comment on Twitter, Shkreli directed CNBC to his lawyer.
In a statement, Shkreli lawyer Ben Brafman said the superseding indictment "adds nothing of value to the government's case that still relies on a flawed theory."
Shkreli was most recently in court May 3. He already was due to return to Brooklyn federal court in the case Monday.
It is not clear if he will be arraigned on the new criminal charge then, or on another day. He is free on a $5 million bond.
A spokeswoman for the U.S. attorney's office in the Eastern District of New York declined to comment.
Shkreli has said he is innocent of the criminal case, in which prosecutors claim he looted his former pharma company Retrophin to pay off investors he was suspected of previously defrauding in a hedge fund he ran. His former lawyer Evan Greebel is a co-defendant in the case.
The new charge is a conspiracy to commit securities fraud count related to unrestricted securities of Retrophin. Prosecutors allege Shkreli and Greebel defrauded potential investors "by concealing Shkreli's beneficial ownership and control of Retrophin's unrestricted or free shares."
It exposes Shkreli to additional prison time.
Greebel's lawyer Reed Brodsky declined to comment.
Shkreli gained notoriety last year after raising the price of a drug used to treat a parasitic disease called toxoplasmosis by more than 5,500 percent as CEO of Turing Pharmaceuticals, the company that he founded after Retrophin's board ousted him. The price of Daraprim jumped to $750 per pill from $13.50 per pill.
Although the price hike drew widespread outrage, it had nothing to do with the criminal charges that were subsequently lodged against him.
In February, investigating drug price increases, citing his Fifth Amendment right against self-incrimination.
Correction: Evan Greebel is a co-defendant in the case. An earlier version misspelled his name.